UCB-0159

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameUCB-0159

Drug Alias NameUCB-0159

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionInterleukin 17A inhibitorsTumor necrosis factor inhibitors

TargetsInterleukin 17ATumor necrosis factor

Therapy Area/IndicationsAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesUcb Sa

China Registration ClassN/A

Develop Information

Active CompaniesUcb

Inactive CompaniesN/A

Active IndicationsAutoimmune Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A